The IRB's Role in Assessing the Generalizability of Non-NIH-Funded Clinical Trials
IRB: A Review of Human Subjects Research. 1998 Mar-Jun; 20(2-3): 1-5.
Age Factors; Clinical Trials; Drug Industry; Drugs; Ethical Review; Ethics; Ethics Committees; Federal Government; Females; Financial Support; Food; Government; Government Financing; Government Regulation; Guidelines; Health; Human Experimentation; Industry; Investigational Drugs; IRB; Minority Groups; Nontherapeutic Research; Regulation; Research; Research Design; Research Ethics; Research Ethics Committees; Review; Selection of Subjects; Therapeutic Research;
Showing items related by title, author, creator and subject.
Assessing the Interpretation of Criteria for Clinical Trial Eligibility: A Survey of Oncology Investigators Weijer, Charles; Freedman, Benjamin; Shapiro, Stanley; Fuks, Abraham; Skrutkowska, Myriam; Sigurjonsdottir, Maria (1998)
Is the Use of Placebo Controls Ethically Permissible in Clinical Trials of Agents Intended to Reduce Fractures in Osteoporosis? Brody, Baruch A.; Dickey, Nancy; Ellenberg, Susan S.; Heaney, Robert P.; Levine, Robert J.; O'Brien, Richard L.; Purtilo, Ruth B.; Weijer, Charles (2003-06)
Skrutkowska, Myriam; Weijer, Charles (1997)